Alex Keun Mo Yang - Chief Executive Officer, Director, 10%+ Owner at Polaryx Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Alex Keun Mo Yang in Polaryx Therapeutics, Inc.

Buys

Open market
Shares
+88,453
Avg price
$4.07
Total value
+$360,004

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+88,453
Share %
100%
Total value
+$360,004

Reported holdings for Alex Keun Mo Yang in Polaryx Therapeutics, Inc.

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Polaryx Therapeutics, Inc.

Security class
Common Stock
Shares / value
24,233,249
Estimated value
$98,629,323
Report date
27 May 2026
Price
$4.07
Ownership
By Mstone Partners Healthcare Limited
Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Polaryx Therapeutics, Inc.

Security class
Common Stock
Shares / value
183,560
Estimated value
$535,995
Report date
29 Jan 2026
Price
$2.92
Ownership
By MBstone Biotech Flagship Limited
Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Polaryx Therapeutics, Inc.

Security class
Common Stock
Shares / value
108,282
Estimated value
$316,183
Report date
29 Jan 2026
Price
$2.92
Ownership
By Mstone Pediaorphan Singapore I Pte. Limited

Transaction history for Alex Keun Mo Yang in Polaryx Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .